FiledIssuerIndustrySold
Mar 2026Rangeley Lake Partners, LPPooled Investment Fund$163M
Mar 2026Immunic, Inc.Biotechnology$200M
Feb 2026AKD Holdings-1 LPPooled Investment Fund$243M
Apr 2025Surrozen, Inc./DEBiotechnology$76M
Aug 2024Tenax Therapeutics, Inc.Pharmaceuticals$100M
Apr 2024Surrozen, Inc./DEBiotechnology$193M
Dec 2023Spyre Therapeutics, Inc.Biotechnology$180M
Sept 2023BV RN Continuation Fund, L.P.Pooled Investment Fund-
Jul 2023Wastefuel Global, Inc.Energy Conservation$10M
Jul 2023Aeglea BioTherapeutics, Inc.Biotechnology$210M
Mar 2023Orchard Therapeutics plcBiotechnology$34M
Feb 2023Ksb-1 Holdings, LPPooled Investment Fund$95M
Feb 2023Ksn-1 Holdings, LPPooled Investment Fund$111M
Sept 2022Iliad Biotechnologies, LLCBiotechnology$43M
Mar 2022Marlette Holdings, Inc.Other Banking and Financial Services$75M
Feb 2022H2scan CorpOther Technology$70M
Sept 2021TMGcore, Inc.Other Technology$20M
Nov 2020Trupanion, Inc.Insurance$60M
Jul 2019Guggenheim Partners Opportunistic Investment Grade Securities Fund 2015, LLCAgents: GUGGENHEIM SECURITIES, LLCPooled Investment Fund$305M
Dec 201799 Cents Only Stores LLCRetailing$140M
Aug 2016Zosano Pharma CorpPharmaceuticals$7.5M
Aug 2016Solar Mosaic, Inc.Other Banking and Financial Services$41M
Jun 2016Aclaris Therapeutics, Inc.Pharmaceuticals$20M
Sept 2015Guggenheim Partners Opportunistic Investment Grade Securities Fund 2015, LLCAgents: GUGGENHEIM SECURITIES, LLCPooled Investment Fund$71M
Sept 2015Guggenheim Loan Fund, Ltd.Agents: GUGGENHEIM SECURITIES, LLCPooled Investment Fund$59M
Dec 2014DL Private Variable Account AOther$60M
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.